ReviewFrontiers in immunology2026
Human pathological findings in Kawasaki disease: a narrative review of autopsy and biopsy evidence.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kawasaki disease (KD) is an acute systemic vasculitis affecting children under five years of age and a leading cause of acquired heart disease in developed countries. Although autopsy and biopsy studies provide important insights into disease progression, integrated summaries combining classical histopathology with modern molecular findings remain limited. Methods: This narrative review searched PubMed and Web of Science from January 1, 1974 to December 31, 2025 for human autopsy and biopsy studies on KD. Findings were synthesized to characterize pathological features across cardiovascular and extracardiac systems, focusing on vascular progression based on the three-process model, multisystem involvement, and underlying molecular and genetic mechanisms. Results: Coronary artery involvement follows a three-process model, including necrotizing arteritis, subacute/chronic vasculitis, and luminal myofibroblastic proliferation, which drives progressive luminal stenosis. The myocardium, pericardium, and cardiac valves are also frequently affected. Extracardiac tissues show intracytoplasmic inclusion bodies and IgA plasma cell infiltration, suggesting a potential infection-triggered mechanism. Key signaling pathways, including TLRs/NF-κB, NLRP3/IL-1β, Ca² Conclusion: KD is a systemic vasculitis primarily targeting the coronary arteries, with a dynamic pathological progression from acute inflammation to chronic vascular remodeling. Future research should focus on prospective pathology studies, long-term vascular remodeling, and underlying molecular mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.